Minimally invasive surgery for HCC
作者机构:Department of SurgeryCollege of MedicineSeoul National University Bundang HospitalSeongnam-siGyeonggi-do 13620South Korea Department of Clinical Medicine and SurgeryMinimally invasive and robotic HPB Surgery UnitFederico II UniversityNaples 80131Italy
出 版 物:《Hepatoma Research》 (肝癌研究(英文版))
年 卷 期:2022年第8卷第1期
页 面:278-283页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
摘 要:After an initial phase of skepticism and technical difficulties,minimally invasive liver surgery(MILS)has become a widespread practice in most high-volume hepatobiliary *** the first laparoscopic liver resection(LLR)was carried out in France in 1991 for a benign lesion,the indications have substantially changed,including malignant diseases such as hepatocellular carcinoma(HCC)[1].Thanks to the improvements in both technical aspects and perioperative management,the extent of resection has also expanded during the last years,including patients with more advanced disease[2].With this redefinition of the boundaries of MILS,liver surgeons must be aware of the specific issues concerning HCC treatment,as well as the current evidence and strategies to overcome old limits.